- Published on
Infectious Disease – Empyema
The accumulation of purulent fluid in the pleural cavity is known as an empyema. Empyema is typically a consequence of bacterial pneumonia, but it can also happen following thoracic surgery, trauma, and a number of other conditions, including esophageal perforation and subdiaphragmatic infection.
Considerations for Children
Streptococcus pneumoniae (mostly serotype 1) causes the majority of childhood empyema; the prognosis for children with empyema is significantly better than for adults, despite the fact that management is the same; pediatric empyema has an incidence of 3.3 per 100,000; most cases are secondary to underlying bacterial pneumoniae; and the prognosis is significantly better in children with empyema than in adults.
The incidence of epidemiology
Up to 57% of pneumonia patients have pleural effusions, and 1% to 2% of simple parapneumonic effusions can progress to empyema.
Prevalence: Pleural infections occur in people of all ages, but they are more prevalent in children and the elderly. Men are twice as likely as women to get them.
Risk factors for aspiration include: diabetes mellitus; alcoholism; substance misuse; rheumatoid arthritis; concurrent chronic lung illness; poor dentition; and anaerobic infection.
• A history of thoracic surgery • The existence of cancer
Genetics According to current genetic research, a variation of the protein tyrosine phosphatase (PTPN22 Trp620) is linked to an increased risk of Gram-positive empyema.
General prevention includes: using the right antibiotics for surgical prophylaxis; treating pneumonia with the right antibiotics; following operating procedures; and receiving the pneumococcal vaccine.
PATHOPHYSIOLOGY
• There are three stages in the development of empyema: exudative with pleural membrane swelling in Stage 1; fibrinopurulent with substantial fibrin deposits in Stage 2; and organized with fibroblast ingrowth and collagen deposits in Stage 3.
ETIOLOGY
• Both hospital-acquired and community-acquired empyema have different bacteriologies and are not the same as pneumonia • Community-acquired empyema: (4) Staphylococci (mostly methicillin-susceptible Staphylococcus aureus) – Streptococci (primarily Streptococcus milleri group and S. pneumoniae) Mycobacterium tuberculosis and Actinomyces species are uncommon. Enterobacteriaceae and Anaerobes (Fusobacterium, Bacteroides, and Peptostreptococcus) are also present.
Methicillin-resistant S. aureus empyema obtained in a hospital Pseudomonas aeringosa, S. milleri group, Enterobacteriaceae, Enterococci, and Anaerobes
COMMONLY ASSOCIATED CONDITIONS
A case of pneumonia
DIAGNOSIS HISTORY
• Symptoms may include fever, chest discomfort, and dyspnea • Elderly and immunocompromised: • Preceding pneumonia or thoracic surgery may show as asymptomatic or with anemia and weight loss.
Physical examination findings include: stony dull percussion; decreased fremitus; lack of breath sounds above effusion; and the possibility that patients with minimal effusion won't have diffusion symptoms.
Initial diagnostic and interpretation lab tests
C-reactive protein (CRP), complete blood count (CBC), and routine chemistry, cytology, and cell count examination of diffusion
A blood gas machine measures the pH of the pleural fluid to be less than 7.2. Gram stain and culture of the effusion, blood, and/or sputum
CRP can be measured repeatedly to see how well therapies are working.
Imaging First Step
On posteroanterior (PA) or lateral chest radiographs, a chest x-ray (CXR) reveals pleural effusion. Ultrasound (US) allows for precise effusion localization and directs chest tube installation.
• Lung abscess and empyema can be distinguished by CT with intravenous contrast; empyema is lenticular in shape and frequently exhibits the "split pleura" sign.
Follow-up and Particular Points to Remember
• To assess pleural effusion, repeated US and CT scans should be performed.
• It's important to make sure that bronchopleural
Does a fistula occur?
Diagnostic Techniques and Other
Thoracentesis: The diagnosis is confirmed by the presence of pus in the pleural cavity.
Pathological Results
Numerous germs, cellular debris, and polymorphonuclear leukocytes were present in the effusion.
DIFFERENTIAL DIAGNOSIS
• Other causes of pleural effusion Abscess in the lung; pneumonia
MEDICATION FOR TREATMENT
• As soon as they are diagnosed, all patients should begin antibiotic medication.
• Empyema requires immediate drainage, typically via a chest tube (5). When the fluid has a lower viscosity, repeated thoracocentesis procedures have been utilized on occasion.
• Because hospital-acquired empyema and community-acquired empyema have different etiologies, the regimens for both conditions differ.
Community-acquired empyema: β-lactamase inhibitor, carbapenems, and aminopenicillin
Metronidazole plus second-generation cephalosporin
Patients with a β-lactam allergy treated with clindamycin monotherapy
Carbapenems, pseudomonas penicillin, third- or fourth-generation cephalosporins, and metronidazole are the treatments for hospital-acquired empyema.
It is recommended to add vancomycin, linezolid, or substitutes for suspected or confirmed methicillin-resistant
Extra Care for Staphylococcus aureus (MRSA)
Overall Actions
• Proper hydration.
• Nutrition: Even with sufficient antibiotics and drainage, this important therapeutic goal should not be disregarded.
Referral Issues
Referral for total pleural cavity evacuation should be taken into consideration as soon as empyema is diagnosed due to its high mortality and morbidity rates.
Other Treatments
• Intrapleural fibrinolytics: Clamp the chest tube for two to four hours before resuming normal drainage after administering streptokinase 250,000 IU or urokinase 100,000 IU in 30 to 60 ml of sterile saline.
Even though streptokinase is frequently used in clinical settings, the MIST 1 trial (6) did not support its involvement in empyema.However, further information is needed.
to make ultimate judgments.
• Thoracoscopy for individuals with a loculated effusion that has not been fully drained at the beginning of the disease;
SURGERY AND OTHER PROCEDURES
• Currently available surgical options include:
VATS stands for video-assisted thoracoscopic surgery. Open thoracotomy with decortications; mini-thoracotomy
For postsurgical empyema, open surgical techniques such as open window thoracoplasty, open debridement, and thoracomyoplasty are thought to be more effective than minimally invasive surgery. Rib resection with open drainage
Considering the patient
First Stabilization
• Drainage Admission Criteria
• Empirical antibiotic therapy
In general, as soon as a patient is diagnosed, they should be admitted.
IV fluids, antibiotics, appropriate hydration therapy, and, in certain situations, intravenous feeding
Nursing: Keep an eye on intravenous fluids and make sure the chest tube drains
There is no universally accepted discharge criteria; instead, decisions are primarily made based on individual experiences. Control of fever, a drop in CRP, and a decrease in pleural fluid are examples of useful indicators of clinical improvement.
Continuing Care Follow-Up Suggestions
The duration of antibiotic treatment is determined by the bacteriology, the effectiveness of pleural drainage, and the rate at which the patient's symptoms resolve. • Patients should receive antibiotics intravenously for at least one week before switching to oral formulation.
• The chest tube should remain in place until the draining fluid turns clear yellow and the volume of pleural drainage per 24 hours is less than 50 ml.
Patient monitoring: CBC and CRP should be repeated throughout the duration; US or CT should be used to monitor pleural drainage; and breathing capacity should be evaluated.
A DIET
Providing a high-nutrition diet
Lung rehabilitation; patient education; adherence to treatment, including medication and drainage; and workload restriction
PROGNOSIS • There are notable variations in the outcome for empyema: Several days in the hospital and weeks of recuperation at home may be necessary for a full recovery. At one year, the mortality rate for empyema ranges from 7 to 33%, but it surpasses 50% in patients with substantial co-morbidity.
The accumulation of purulent fluid in the pleural cavity is known as an empyema. Empyema is typically a consequence of bacterial pneumonia, but it can also happen following thoracic surgery, trauma, and a number of other conditions, including esophageal perforation and subdiaphragmatic infection.
Considerations for Children
Streptococcus pneumoniae (mostly serotype 1) causes the majority of childhood empyema; the prognosis for children with empyema is significantly better than for adults, despite the fact that management is the same; pediatric empyema has an incidence of 3.3 per 100,000; most cases are secondary to underlying bacterial pneumoniae; and the prognosis is significantly better in children with empyema than in adults.
The incidence of epidemiology
Up to 57% of pneumonia patients have pleural effusions, and 1% to 2% of simple parapneumonic effusions can progress to empyema.
Prevalence: Pleural infections occur in people of all ages, but they are more prevalent in children and the elderly. Men are twice as likely as women to get them.
Risk factors for aspiration include: diabetes mellitus; alcoholism; substance misuse; rheumatoid arthritis; concurrent chronic lung illness; poor dentition; and anaerobic infection.
• A history of thoracic surgery • The existence of cancer
Genetics According to current genetic research, a variation of the protein tyrosine phosphatase (PTPN22 Trp620) is linked to an increased risk of Gram-positive empyema.
General prevention includes: using the right antibiotics for surgical prophylaxis; treating pneumonia with the right antibiotics; following operating procedures; and receiving the pneumococcal vaccine.
PATHOPHYSIOLOGY
• There are three stages in the development of empyema: exudative with pleural membrane swelling in Stage 1; fibrinopurulent with substantial fibrin deposits in Stage 2; and organized with fibroblast ingrowth and collagen deposits in Stage 3.
ETIOLOGY
• Both hospital-acquired and community-acquired empyema have different bacteriologies and are not the same as pneumonia • Community-acquired empyema: (4) Staphylococci (mostly methicillin-susceptible Staphylococcus aureus) – Streptococci (primarily Streptococcus milleri group and S. pneumoniae) Mycobacterium tuberculosis and Actinomyces species are uncommon. Enterobacteriaceae and Anaerobes (Fusobacterium, Bacteroides, and Peptostreptococcus) are also present.
Methicillin-resistant S. aureus empyema obtained in a hospital Pseudomonas aeringosa, S. milleri group, Enterobacteriaceae, Enterococci, and Anaerobes
COMMONLY ASSOCIATED CONDITIONS
A case of pneumonia
DIAGNOSIS HISTORY
• Symptoms may include fever, chest discomfort, and dyspnea • Elderly and immunocompromised: • Preceding pneumonia or thoracic surgery may show as asymptomatic or with anemia and weight loss.
Physical examination findings include: stony dull percussion; decreased fremitus; lack of breath sounds above effusion; and the possibility that patients with minimal effusion won't have diffusion symptoms.
Initial diagnostic and interpretation lab tests
C-reactive protein (CRP), complete blood count (CBC), and routine chemistry, cytology, and cell count examination of diffusion
A blood gas machine measures the pH of the pleural fluid to be less than 7.2. Gram stain and culture of the effusion, blood, and/or sputum
CRP can be measured repeatedly to see how well therapies are working.
Imaging First Step
On posteroanterior (PA) or lateral chest radiographs, a chest x-ray (CXR) reveals pleural effusion. Ultrasound (US) allows for precise effusion localization and directs chest tube installation.
• Lung abscess and empyema can be distinguished by CT with intravenous contrast; empyema is lenticular in shape and frequently exhibits the "split pleura" sign.
Follow-up and Particular Points to Remember
• To assess pleural effusion, repeated US and CT scans should be performed.
• It's important to make sure that bronchopleural
Does a fistula occur?
Diagnostic Techniques and Other
Thoracentesis: The diagnosis is confirmed by the presence of pus in the pleural cavity.
Pathological Results
Numerous germs, cellular debris, and polymorphonuclear leukocytes were present in the effusion.
DIFFERENTIAL DIAGNOSIS
• Other causes of pleural effusion Abscess in the lung; pneumonia
MEDICATION FOR TREATMENT
• As soon as they are diagnosed, all patients should begin antibiotic medication.
• Empyema requires immediate drainage, typically via a chest tube (5). When the fluid has a lower viscosity, repeated thoracocentesis procedures have been utilized on occasion.
• Because hospital-acquired empyema and community-acquired empyema have different etiologies, the regimens for both conditions differ.
Community-acquired empyema: β-lactamase inhibitor, carbapenems, and aminopenicillin
Metronidazole plus second-generation cephalosporin
Patients with a β-lactam allergy treated with clindamycin monotherapy
Carbapenems, pseudomonas penicillin, third- or fourth-generation cephalosporins, and metronidazole are the treatments for hospital-acquired empyema.
It is recommended to add vancomycin, linezolid, or substitutes for suspected or confirmed methicillin-resistant
Extra Care for Staphylococcus aureus (MRSA)
Overall Actions
• Proper hydration.
• Nutrition: Even with sufficient antibiotics and drainage, this important therapeutic goal should not be disregarded.
Referral Issues
Referral for total pleural cavity evacuation should be taken into consideration as soon as empyema is diagnosed due to its high mortality and morbidity rates.
Other Treatments
• Intrapleural fibrinolytics: Clamp the chest tube for two to four hours before resuming normal drainage after administering streptokinase 250,000 IU or urokinase 100,000 IU in 30 to 60 ml of sterile saline.
Even though streptokinase is frequently used in clinical settings, the MIST 1 trial (6) did not support its involvement in empyema.However, further information is needed.
to make ultimate judgments.
• Thoracoscopy for individuals with a loculated effusion that has not been fully drained at the beginning of the disease;
SURGERY AND OTHER PROCEDURES
• Currently available surgical options include:
VATS stands for video-assisted thoracoscopic surgery. Open thoracotomy with decortications; mini-thoracotomy
For postsurgical empyema, open surgical techniques such as open window thoracoplasty, open debridement, and thoracomyoplasty are thought to be more effective than minimally invasive surgery. Rib resection with open drainage
Considering the patient
First Stabilization
• Drainage Admission Criteria
• Empirical antibiotic therapy
In general, as soon as a patient is diagnosed, they should be admitted.
IV fluids, antibiotics, appropriate hydration therapy, and, in certain situations, intravenous feeding
Nursing: Keep an eye on intravenous fluids and make sure the chest tube drains
There is no universally accepted discharge criteria; instead, decisions are primarily made based on individual experiences. Control of fever, a drop in CRP, and a decrease in pleural fluid are examples of useful indicators of clinical improvement.
Continuing Care Follow-Up Suggestions
The duration of antibiotic treatment is determined by the bacteriology, the effectiveness of pleural drainage, and the rate at which the patient's symptoms resolve. • Patients should receive antibiotics intravenously for at least one week before switching to oral formulation.
• The chest tube should remain in place until the draining fluid turns clear yellow and the volume of pleural drainage per 24 hours is less than 50 ml.
Patient monitoring: CBC and CRP should be repeated throughout the duration; US or CT should be used to monitor pleural drainage; and breathing capacity should be evaluated.
A DIET
Providing a high-nutrition diet
Lung rehabilitation; patient education; adherence to treatment, including medication and drainage; and workload restriction
PROGNOSIS • There are notable variations in the outcome for empyema: Several days in the hospital and weeks of recuperation at home may be necessary for a full recovery. At one year, the mortality rate for empyema ranges from 7 to 33%, but it surpasses 50% in patients with substantial co-morbidity.
0 Comments
